Urothelial Carcinoma Clinical Trials

384 clinical trials for Urothelial Carcinoma across international registries, including 95 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• C5731001 - An Open-label, Randomized, Controlled Phase 3 Study of Disitamab Vedotin in Combination with Pembrolizumab Versus Chemotherapy in Subjects with Previously Untreated Locally Advanced or Metastatic Urothelial Carcinoma that Expresses HER2 (IHC 1+ and Greater) — RECRUITING · PHASE3
• A Study of GEN1106 in Participants With Solid Tumors — RECRUITING · PHASE1
• A Study to Assess Safety, Tolerability and Imaging Characteristics of [68Ga]Ga-DPI-4452 and to Assess Safety, Tolerability, and Efficacy of [177Lu]Lu-DPI-4452 in Participants With Unresectable Locally Advanced or Metastatic Solid Tumors — RECRUITING · PHASE1
• Validation of a Circulating Tumor DNA Blood Test in Muscle-Invasive Bladder and Upper Tract Urothelial Cancer — RECRUITING
• Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors — RECRUITING · PHASE1
• A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors — RECRUITING · PHASE1
• The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas — RECRUITING · PHASE2
• Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist) — RECRUITING · PHASE1
• A Study of HLX18 vs. OPDIVO® in Multiple Resected Solid Tumors — RECRUITING · PHASE1
• DBC-664 in Adult Patients With Solid Tumors — RECRUITING · PHASE1
• A Study of BL-B01D1 + PD-1 in Patients With Locally Advanced or Metastatic Urothelial Carcinoma — RECRUITING · PHASE2
• A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2 — RECRUITING · PHASE2
• Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer — RECRUITING · PHASE1
• A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors — RECRUITING · PHASE1
• Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors — RECRUITING · PHASE1
• Study of Neoadjuvant Enfortumab Vedotin and Pembrolizumab in Upper Tract Urothelial Cancer — RECRUITING · PHASE2
• Study of DCC-2812 in Participants With Advanced Genitourinary Cancers — RECRUITING · PHASE1
• Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis — RECRUITING · PHASE1
• Registry Platform Urologic Cancer — RECRUITING
• A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors — RECRUITING · PHASE2
• Non-invasive Urinary Genomics-Based Risk Assessment for Early Urothelial Carcinoma Diagnosis — RECRUITING
• A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors — RECRUITING · PHASE1
• Locally Ablative TherapY in Oligo-ProgressiVe GEnitourinary TumoRs (LAYOVER) — RECRUITING · NA
• A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors — RECRUITING · PHASE1
• A Study of BMS-986504 With Standard-of-Care Therapy for People With Solid Tumor Cancer — RECRUITING · PHASE1
• Specimen Collection for Validation of UroAmp: A Next Generation Sequencing Platform for Detection and Surveillance of Bladder Cancer — RECRUITING
• A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer — RECRUITING · PHASE3
• Research of Double-positive Circulating Cells (Tumor Marker / CD45+) in Several Types of Metastatic Cancers — RECRUITING · NA
• Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program — RECRUITING · PHASE2
• Enfortumab Vedotin and Pembrolizumab in People With Bladder Cancer — RECRUITING · PHASE2
• Safety and Tolerability Study of 68Ga/177Lu-BRP-020063 in Advanced Solid Tumors — RECRUITING · PHASE1
• A Study of Neuropathy Caused by Enfortumab Vedotin in People With Urothelial Carcinoma — RECRUITING
• A Substudy of Investigational Agents in Programmed Cell Death-1/Ligand 1 (PD-1/L1) Refractory Locally Advanced or Metastatic Urothelial Carcinoma (mUC) (MK-3475-04A) — RECRUITING · PHASE1
• C5731002 - A Phase 2 Multi-Cohort, Open-Label, Multi-Center Clinical Study Evaluating the Efficacy and Safety of Disitamab Vedotin (RC48-ADC) Alone or in Combination with Pembrolizumab in Subjects with Locally-Advanced Unresectable or Metastatic Urothelial Carcinoma That Expresses HER2 — RECRUITING · PHASE2
• Comparison of CT and MR (VI-RADS) Imaging for Local Bladder Cancer Staging — RECRUITING
• GI-101/GI-101A as a Single Agent or in Combination With Pembrolizumab or Lenvatinib in Advanced Solid Tumors — RECRUITING · PHASE1
• A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours — RECRUITING · PHASE1
• 18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors — RECRUITING · NA
• Bladder Cancer Screening Trial — RECRUITING · NA
• Adjuvant Sacituzumab Govitecan and Nivolumab in Muscle-Invasive Urothelial Carcinoma at High-Risk Recurrence — RECRUITING · PHASE2
• Randomized Trial of stAndard of Care With or Without Metastases-directed Stereotactic Body Radiation Therapy in Patients Affected by Oligometastatic uRothelial carcinomA — RECRUITING · NA
• Phase II Study of Trastuzumab Rezetecan or in Combination With Adebrelimab in HER2-Expressing Locally Advanced or Metastatic Urothelial Carcinoma (la/mUC) — RECRUITING · PHASE2
• Detection and Risk Stratification in Veterans Presenting With Microscopic Hematuria — RECRUITING
• A Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With Recurrent or Metastatic Urothelial Carcinoma(PANKU-Bladder01) — RECRUITING · PHASE3
• Intravesical GEM/DOCE for HR BCG-Unresponsive NMIBC — RECRUITING · PHASE2
• Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma — RECRUITING · PHASE1
• This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors — RECRUITING · PHASE1
• Trastuzumab in Combination With Serplulimab and Chemotherapy for the Treatment of HER2-overexpressing Unresectable Locally Advanced or Metastatic Biliary Tract Cancer or Urothelial Carcinoma After Failure of Standard Therapy — RECRUITING · PHASE2
• Dual-Target Nectin-4/HER2 CAR-NK Cells in Advanced Urothelial Carcinoma — RECRUITING · PHASE1
• Bio Clinical Collection of Urothelial Carcinoma — RECRUITING

Refine this search